Baylor College Of Medicine

Neurotrophic keratitis is historically a rare disease, but now that more understanding has been gained of the underlying etiology and manifestations, its prevalence is starting to increase, and more cases are seen in clinics.

SAN DIEGO — Patients underrepresented in pivotal trials of anti-CD19 chimeric antigen receptor T-cell therapy may still derive benefit from the treatment modality, according to a speaker at ASH Annual Meeting and Exposition.

ASH has announced its three inaugural quality improvement champions.

Results presented at the American Society for Surgery of the Hand Annual Meeting showed deep-learning AI models may be able to make accurate clinical decisions regarding whether reduction is needed for a distal radius fracture.

Extended lymphadenectomy offered no survival benefit for patients with localized muscle-invasive bladder cancer compared with bilateral standard lymphadenectomy for patients undergoing radical cystectomy, according to study findings.

Children and young adults with relapsed or refractory B-cell acute lymphoblastic leukemia increasingly receive tisagenlecleucel in earlier settings when they have lower disease burden, according to findings presented at ASCO Annual Meeting.

In academic ophthalmology, the presence of women has increased over time.

Amniotic umbilical cord tissue may be an effective adjunctive therapy in patients undergoing meniscectomy, according to published results.

CHICAGO — Time between therapy regimens can safely be offered to certain children with cancer to promote quality of life and explore goals of care without negatively affecting survival, according to data presented at ASCO Annual Meeting.

A novel immunotherapy involving HER2-specific chimeric antigen receptor T cells produced clinically beneficial results for multiple individuals with advanced sarcomas, according to results of a phase 1 trial published in Nature Cancer.